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Introduction
The Nodal and Notch signaling pathways perform crucial roles 
in regulating various stages of embryonic development (Bolós 
et al., 2007; Shen, 2007). Nodal is a member of the TGF- fam-
ily; its signaling activity is required to establish the anterior– 
posterior and the left–right body axes and to determine cell 
lineages for the initiation of gastrulation (Shen, 2007). Nodal 
utilizes a shared Smad2/3-dependent signaling pathway with 
other TGF- family ligands such as activin or TGF-. Unlike 
other TGF- family ligands, Nodal requires glycosylphos-
phatidylinositol-anchored  coreceptors,  EGF–Cripto-1/FRL-1/ 
Cryptic (CFC) family proteins which include human and mouse 
Cripto-1  (CR-1/Cr-1)  and  Cryptic  (CFC1),  for  activation  of 
Alk4/ActRIIB receptor signaling (Strizzi et al., 2005).
Notch signaling regulates a variety of developmental pro-
cesses, including asymmetric cell division, left–right asym-
metry, somitogenesis, and development of various types of organ 
systems such as the central nervous and cardiovascular systems 
(Bolós  et  al.,  2007).  Mammals  have  four  Notch  receptors 
(Notch1–4) and five membrane-bound ligands (Dll1, -3, and -4 
and Jagged-1 and -2). Mature Notch receptors are expressed as 
heteromeric single-pass transmembrane proteins after proteo-
lytic maturation by furin-like protein convertase (S1 cleavage). 
Ligand binding induces sequential cleavage of Notch receptors 
at the extracellular domain (ECD) by ADAM (a disintegrin and 
metalloprotease) proteinase (S2 cleavage) and at the transmem-
brane domain by a -secretase enzyme complex (S3 cleavage), 
releasing an intracellular domain (ICD). The Notch ICD then 
translocates to the nucleus, where it associates with the DNA-
binding protein CBF1 (CSL/RBPJ-) to regulate the transcrip-
tion of multiple effecter genes, including members of the HES/HEY 
family (Bolós et al., 2007).
In this study, we discovered an unexpected function of EGF-
CFC proteins in the Notch signaling pathway. Our findings provide 
a new insight into Notch and Nodal/CR-1 signaling pathways.
  N
odal  and  Notch  signaling  pathways  play  es-
sential roles in vertebrate development. Through 
a  yeast  two-hybrid  screening,  we  identified 
Notch3  as  a  candidate  binding  partner  of  the  Nodal   
coreceptor Cripto-1. Coimmunoprecipitation analysis con-
firmed the binding of Cripto-1 with all four mammalian 
Notch receptors. Deletion analyses revealed that the bind-
ing of Cripto-1 and Notch1 is mediated by the Cripto-1/ 
FRL-1/Cryptic domain of Cripto-1 and the C-terminal re-
gion of epidermal growth factor–like repeats of Notch1. 
Binding of Cripto-1 to Notch1 occurred mainly in the   
endoplasmic reticulum–Golgi network. Cripto-1 expression 
resulted in the recruitment of Notch1 protein into lipid raft 
microdomains and enhancement of the furin-like protein 
convertase-mediated  proteolytic  maturation  of  Notch1 
(S1 cleavage). Enhanced S1 cleavage resulted in the sen-
sitization to ligand-induced activation of Notch signaling. 
In addition, knockdown of Cripto-1 expression in human 
and mouse embryonal carcinoma cells desensitized the 
ligand-induced Notch signaling activation. These results 
suggest a novel role of Cripto-1 in facilitating the post-
translational maturation of Notch receptors.
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We then attempted to identify the binding domains within 
CR-1 and the Notch receptors using a series of deletion mutants 
(Fig. 2, A and B). Whereas a deletion of the EGF-like domain of 
CR-1 (EGF) still retained its binding affinity for Notch1, dele-
tion of the CFC domain (CFC) diminished the ability of CR-1 
to interact with Notch1 (Fig. 2 C). Deletion of both the EGF-like 
and CFC domains (EC) was required to completely abolish the 
interaction with Notch1 (Fig. 2 C). This suggested that the CFC 
domain of CR-1 is primarily responsible for mediating the bind-
ing to Notch1. We also performed deletion experiments with the 
Notch1 protein (Fig. 2, D–F). Deletion of all three Lin12 repeats 
(LNR) of Notch1 did not affect the Notch1–CR-1 interaction 
(Fig. 2 D), suggesting that the EGF-like repeats of Notch1 are re-
sponsible for the Notch1–CR-1 binding. To test whether binding 
of CR-1 is specific for the EGF-like repeats of Notch receptors, 
we replaced all of the EGF-like repeats with EGF-like repeats of 
a Notch ligand Dll1 (DlEGF + NEGF and DlEGF + NECD). 
DlEGF + NEGF and DlEGF + NECD failed to interact with 
CR-1 (Fig. 2 D). CR-1 also did not bind to FL Dll1 (Fig. 2 E). 
These data suggest that CR-1 binding is specific to the EGF-like 
repeats of Notch1. Constructs containing up to the first six EGF-
like repeats of Notch1 (2×, 4×, and 6× EGF) were not sufficient 
to efficiently bind CR-1 (Fig. 2 D). Similarly, the Notch1 ICD 
did not show any binding to CR-1 (Fig. 2 D), confirming that the 
interaction between CR-1 and Notch1 is mediated by the ECD 
of Notch1. To further identify the precise location of the CR-1– 
interacting EGF-like repeats in Notch1, we generated deletion con-
structs lacking EGF-like repeats 8–24 (EGF8–24 and MfeI), 
a region which is essential for ligand binding (Ge et al., 2008). 
These two constructs were able to bind to CR-1 with an affin-
ity similar to FL Notch1, suggesting that the binding of Notch1 
to CR-1 is independent of the ligand-binding domain of Notch1 
(Fig. 2 E). To pinpoint the EGF-like repeats responsible for   
CR-1 binding, we generated artificial constructs containing seven 
of the C-terminal EGF-like repeats (N1EGF30-YFP), the last two 
EGF-like repeats (N1EGF35-YFP), or only the LNR (N1LNR-
YFP). Co-IP assays revealed that the binding of N1EGF30- and 
N1EGF35-YFP to CR-1 was comparable with the positive con-
trol N2FL-Myc, but the binding to CR-1 was dramatically re-
duced with N1LNR-YFP (Fig. 2 F). This suggests that the last 
two EGF-like repeats are necessary and sufficient for CR-1 bind-
ing. This result is in agreement with the region in Notch3 that   
was detected by the Y2H screen because this prey fragment 
Results and discussion
It has been suggested that EGF-CFC proteins function indepen-
dently of Nodal in vertebrate development (Warga and Kane, 
2003; D’Andrea et al., 2008). Therefore, we assumed that there 
may exist unknown binding partners of CR-1. To discover novel 
binding partners of CR-1, we used a yeast two-hybrid (Y2H) 
screening approach. A core peptide sequence of human CR-1   
(aa 34–161) was used as a bait to screen a mouse embryo or 
human colon cDNA prey library for potential binding partners.   
A prey encoding mouse Notch3 (aa 1,290–1,478) was isolated 
from the screening after passage through two auxotrophic report-
ers. Five additional candidate genes were also isolated through 
this screening procedure (Table I). Two of six candidate pro-
teins comprised secreted or cell-associated extracellular proteins, 
EFEMP2  and  Notch3,  both  of  which  contain  large  EGF-like   
repeats. To confirm the interaction between CR-1 and Notch3 in 
a mammalian expression system, coimmunoprecipitation (co-IP) 
assays were performed using Flag-tagged CR-1 (CR-Flag) and 
HA-tagged full-length (FL) Notch3 (N3FL-HA) in transiently 
transfected COS-7 cells (Fig. 1 C). N3FL-HA was pulled down 
by anti-Flag antibody only in the presence of CR-Flag, and, vice 
versa, CR-Flag was pulled down by anti-HA antibody only in the 
presence of N3FL-HA. We also detected similar interactions of 
CR-1 with other Notch receptors (Notch1, -2, and -4; Fig. 1, A, B, 
and D, respectively). These interactions were observed with other 
cell lines such as CHO or 293T cells, suggesting that the bind-
ing of CR-1 to Notch is not cell type specific (unpublished data).   
CR-1 preferentially bound to the FL Notch precursors (300 kD) 
but not to the cleaved forms (120 kD). To detect the interaction of 
endogenous proteins, we used NTERA2/D1 human embryonal 
carcinoma (EC) cells, which express high levels of CR-1 as well 
as Notch receptors (Fig. 1 E; Ciccodicola et al., 1989; Walsh and 
Andrews, 2003). We used two polyclonal antibodies, C20 and 
AF5317, which recognize the ICD and ECD of Notch1, respec-
tively, for Notch IP. Both antibodies coimmunoprecipitated en-
dogenous CR-1 protein (Fig. 1 F). Reciprocally, the 300-kD 
forms of endogenous Notch1 and -2 were pulled down with the 
endogenous CR-1 protein (Fig. 1 G). We also confirmed the bind-
ing of endogenous mouse Cr-1 and Notch1 proteins in F9 mouse 
EC cells (Fig. S1 A). In addition to CR-1, the other member of 
the EGF-CFC family, CFC1, was also able to bind to the Notch1 
protein (Fig. 1 H).
Table I.  Candidate binding partners of CR-1 from Y2H screening
Bait Bait aa coordinates Prey Gene ID Prey aa coordinates Library
Human TDGF1 34–161 AHNAK 79026 5,648–5,891 Human colon
Human TDGF1 34–161 mCDH4
a 107932 1,591–1,865 
1,591–1,903 
1,590–1,720
Mouse embryo
Human TDGF1 34–161 mEFEMP2 58859 256–440 Mouse embryo
Human TDGF1 34–161 mHUWE1 59026 3,494–3,736 Mouse embryo
Human TDGF1 34–161 mPLSCR3 70310 19–297 Mouse embryo
Human TDGF1 34–161 mNotch3 18131 1,290–1,478 Mouse embryo
Gene identification (ID) numbers are from the Entrez Gene database.
aThree independent clones were identified.345 Interaction between Cripto-1 and Notch receptors • Watanabe et al.
Figure 1.  CR-1 physically associates with all four Notch receptors. (A–D) Flag-tagged CR-1 (CR-Flag) was cotransfected with HA-tagged Notch1 (N1FL-HA; A),   
Myc-tagged Notch2 (N2FL-Myc; B), HA-tagged Notch3 (N3FL-HA; C), and V5-tagged Notch4 (N4FL-V5; D) in COS-7 cells. IP and immunoblotting (IB) 
were performed with the indicated antibodies. cl., cleaved Notch proteins; fl., FL Notch proteins. (E) Nonquantitative RT-PCR for Notch receptor expression 
in NTERA2/D1 cells. M, markers. (F and G) Interaction between endogenous CR-1 and Notch1/2 in NTERA2/D1 cells. (F) Notch1 IP was performed 
using anti-Notch1 polyclonal antibodies (C20 and AF5317). (G) CR-1 IP was performed with anti–CR-1 goat polyclonal antibody (–CR-1). Normal goat 
or sheep IgGs were used as negative controls. Proteins were detected with the indicated antibodies. (H) Flag-tagged CFC1 (CFC-Flag) was cotransfected 
with N1FL-HA, and co-IP was performed as described in A–D.JCB • VOLUME 187 • NUMBER 3 • 2009   346
mass (300 kD). A 120-kD form of Notch was enriched in 
SA-precipitated samples as described previously (Bush et al., 
2001). We did not observe any detectable cell surface bind-
ing of Notch1 to CR-1 in the sequentially immunoprecipitated 
sample. These data suggest that CR-1 binding to Notch1 occurs 
mainly within the cell, even though we cannot entirely exclude 
the possibility of any cell surface interaction between Notch1 and   
CR-1, which might be below the limit of detection by this assay   
method. In addition, the binding of CR-1 to Notch1 interaction 
was independent of glycosylation because treatment with   
tunicamycin did not affect this binding (Fig. 3 B). The mobility 
shift of CR-1 and of the FL form of Notch1 confirmed that both 
proteins underwent protein glycosylation. Confocal analysis 
of GFP-labeled CR-1 and HA-tagged Notch1 (N1FL-HA) re-
vealed that both proteins showed a typical perinuclear vesicular 
pattern, suggesting an ER/Golgi localization (Fig. 3 C and 
Fig. S2, A and B). Analysis with higher magnification revealed 
that these two proteins can colocalize mainly in the same intra-
cellular vesicles. Finally, brefeldin A (BFA) treatment, which 
interferes with Golgi to membrane trafficking and almost com-
pletely blocks cell surface expression of CR-1 (Fig. 3 D), did not 
(aa 1,290–1,478) contained the last two EGF-like repeats (EGF33 
and -34) and LNR 1 and 2 domains of Notch3. Moreover, we also 
demonstrated that Notch3 binds to CR-1 through the ECD (Fig. S1, 
B–D). A Notch3 mutant (R1031C), which causes a CADASIL 
(cerebral autosomal dominant arteriopathy with subcortical in-
farcts and leukoencephalopathy), did not affect the interaction 
between CR-1 and Notch3 (Fig. S1, B–D).
To ascertain whether CR-1 binding to Notch1 occurs   
on the cell surface, we performed a surface biotinylation assay 
followed by co-IP (Fig. 3 A). We were able to distinguish 
biotinylated CR-1 protein by an SDS-PAGE mobility shift be-
cause each PEG4-biotin molecule has an 0.5-kD molecular 
mass and the native CR-1 protein is relatively small (28 kD). 
When the biotinylated sample was precipitated with strepta-
vidin (SA) beads, biotinylated as well as unbiotinylated CR-1 
were pulled down. This suggests that the unbiotinylated form 
of CR-1 is bound to other cell surface biotinylated protein or 
proteins. In fact, when the sample was sequentially precipitated 
with anti-Flag and SA beads, only the biotinylated form of   
CR-1 was precipitated. Biotinylated Notch1 was indistinguish-
able by size because the Notch1 molecule has a large molecular 
Figure 2.  Deletion analysis of the CR-1–Notch interaction. (A) CR-1 deletions. (B) Notch1 deletions/chimeras. (C–F) Co-IP was performed using anti-Flag 
(C), anti-HA (D and E), or anti-Myc (F) affinity beads. Proteins were detected with the indicated antibodies. cl., cleaved Notch proteins; EV, empty vector; 
fl., FL Notch proteins; IB, immunoblot; S.S., signal sequence.347 Interaction between Cripto-1 and Notch receptors • Watanabe et al.
assay system (TP-1 reporter) after ligand stimulation in a co- 
culture assay (Fig. 4 A). When CHO cells transfected with the 
TP-1 reporter were stimulated by co-culture with wild-type (WT) 
or ligand-expressing L cells (L-WT, L-Dll1, or L–Jagged-1),   
the signal enhancement by these ligands was subtle but detect-
able (Fig. 4 A). However, when the FL Notch1 (N1FL) was 
affect the binding of CR-1 to Notch1 (Fig. 3 E). These results 
suggest that the binding between CR-1 and Notch1 may occur 
inside the cell and possibly before or during protein processing 
in the ER/Golgi complex.
To assess whether the binding of CR-1 to Notch1 may af-
fect Notch signaling, we used a CBF1-dependent Notch reporter 
Figure 3.  Intracellular interaction of CR-1 and Notch1. (A) Cell surface biotinylation assay. Transiently transfected COS-7 cells were treated with   
N-hydroxysuccinimide–PEG4-biotin. Co-IP or sequential co-IP was performed with the indicated antibodies. Each indicated band corresponds as follows: 
1, biotinylated CR-1; 2, unbiotinylated and glycosylated CR-1; 3, unbiotinylated and unglycosylated CR-1; 4, carryover of 3× Flag peptides used for 
Flag elution. (B) Effect of glycosylation on the CR-1–Notch1 interaction. COS-7 cells were treated with vehicle or 10 µg/ml tunicamycin for 16 h after 
transient transfection. Co-IP assays were performed reciprocally. (C) Intracellular localization of CR-1 and Notch1. GFP-tagged CR-1 and N1FL-HA were 
visualized by a confocal microscope. (D) Cell surface expression of CR-1 after BFA treatment. Transiently transfected COS-7 cells were treated with the 
indicated concentrations of BFA for 16 h. Cells were stained with PE-conjugated anti–CR-1 mAb, and FACS analysis was performed. (E) Transiently 
transfected COS-7 cells were treated with vehicle or 2 µg/ml BFA for 16 h, and the co-IP experiment was performed using the indicated antibodies.   
cl., cleaved Notch proteins; fl., FL Notch proteins; IB, immunoblot.JCB • VOLUME 187 • NUMBER 3 • 2009   348
as furin or PACE4 (Blanchet et al., 2008). Because processing 
by furin-like convertases (S1 cleavage) is also a prerequisite to 
generate mature heterodimerized Notch receptors (Logeat et al., 
1998), we hypothesized that CR-1 may affect this processing 
step. Similar to the sequestration of the Nodal precursor pro-
tein into lipid rafts (Blanchet et al., 2008), forced expression of 
CR-1 in CR-1–deficient CHO cells enhanced the localization 
coexpressed, the ligand-induced TP-1 reporter activity was 
strongly potentiated. Ectopic expression of CR-1 significantly 
enhanced this ligand-induced TP-1 reporter activation. This   
effect of CR-1 was not observed with exogenous soluble CR-1 
protein (Fig. S2 C).
A recent study has shown that Cr-1 controls processing of 
the Nodal proprotein by recruiting proprotein convertases such 
Figure 4.  Sensitization of the Notch signaling pathway by CR-1. (A) TP-1 reporter assay of co-cultured CHO cells with L-WT, L-Dll1, or L–Jagged-1 cells. 
CHO cells were transiently transfected with empty vector (EV) or WT CR-1 expression vector before co-culture. Cotransfection of FL Notch1 (N1FL) was also 
performed. Mean ± SD is shown for three independent experiments. *, P < 0.05. (B) Sucrose gradient isolation of lipid rafts in transiently transfected CHO 
cells. Fractions 4–5 correspond to the lipid raft fractions. Transferrin receptor (TfR) or Cholera toxin B (CTxB) was used as a nonraft or lipid raft marker, 
respectively. IB, immunoblot. (C) S1 cleavage sites of Notch1. ANK, ankyrin domain; S.S., signal sequence; TM, transmembrane domain. (D and E) En-
hancement of S1 cleavage of Notch1 by CR-1 expression. CHO cells transiently transfected with the indicated amount of expression vectors were incubated 
with 10 µM DAPT for 24 h and analyzed by Western blotting. Mean ± SD of densitometric quantification is shown for three independent transfections (E). 
(F) Blockade of CR-1–induced Notch processing by a furin inhibitor. Transiently transfected CHO cells were treated with the indicated concentrations of a 
furin inhibitor, Decanoyl-RVKR-chloromethylketone, for 24 h, and Notch processing was analyzed as described in D. (G) Enhanced cell surface expression 
of Notch1 by CR-1. CHO cells were transfected with the indicated expression vectors, and the cell surface expression level of Notch1 was assessed by 
FACS analysis. Arrows indicate the peaks of Notch1-transfected populations.349 Interaction between Cripto-1 and Notch receptors • Watanabe et al.
but to a much lesser extent (Fig. 4, D and E). The enhanced 
cleavage of Notch1 by CR-1 is mediated by furin-like conver-
tase because the treatment with a furin inhibitor (Decanoyl-
RVKR-chloromethylketone)  dose-dependently  inhibited  the 
cleavage of Notch1 protein (Fig. 4 F). In addition, we have 
demonstrated that coexpression of CR-1 increased the cell sur-
face expression of Notch1 as demonstrated for Nodal (Blanchet 
et al., 2008), suggesting that CR-1 may have a role for mem-
brane trafficking as well as proteolytic maturation of Notch re-
ceptors (Fig. 4 G).
of the FL Notch1 protein in the lipid raft fraction in which   
glycosylphosphatidylinositol-anchored proteins such as CR-1 are 
enriched (Fig. 4 B). Furthermore, we assessed the effect of CR-1 
expression on S1 cleavage of Notch1 in the presence of the 
-secretase inhibitor DAPT to exclude the effect on ligand- 
induced S3 cleavage (Fig. 4, C and D). CR-1 expression caused 
a dose-dependent increase in enhancement of the cleaved form 
of Notch1. This cleavage enhancement could also be demon-
strated with a Notch1 mutant (N1-RQRR) in which one of the 
furin cleavage sites was deleted (Fig. 4 C; Logeat et al., 1998) 
Figure  5.  Functional  interaction  between   
endogenous  CR-1  and  Notch1  in  EC  cells.  
(A–C) Endogenous expression of CR-1 and Notch 
receptors in F9 WT and Cr
/ cells. (A) Non-
quantitative  RT-PCR.  Samples  treated  without 
reverse transcription (RT) were used as nega-
tive controls. (B) Quantitative RT-PCR. Mean ±   
SD  is  shown  for  four  independent  cultures.   
*, P < 0.05 compared with F9 WT. (C) West-
ern  blot  analysis.  Empty  vector–  and  N1FL-
transfected  CHO  cells  (CHO  EV  and  N1FL) 
were used as negative and positive controls, 
respectively. cl., cleaved Notch proteins; fl., FL 
Notch proteins. (D and E) FACS analysis for the 
cell surface expression of endogenous Notch1 
in  F9  cells.  Mean  ±  SD  is  shown  for  three   
independent  cultures  (E).  *,  P  =  0.021.   
(F) Effect of Cr-1 knockdown on ligand-induced 
TP-1 reporter activity in F9 cells. Transiently trans-
fected F9 WT or Cr
/ cells were co-cultured 
with L-WT, L-Dll1, or L–Jagged-1 cells. Cotrans-
fection of N1FL was also performed. Mean ± 
SD of relative values of relative luciferase units 
is  shown  for  four  independent  experiments.   
*, P < 0.05. (G and H) siRNA knockdown 
of CR-1 in NTERA2/D1 cells. Suppression of 
CR-1 protein by siCR-1_1 and siCR-1_2 was 
evaluated by Western blotting (G) and FACS 
analysis (H, left). GFP was used as an indica-
tor of transfection efficiency (>95%; H, right). 
(I) Effect of CR-1 knockdown on ligand-induced 
Notch  target  gene  expression  in  NTERA2/ 
D1 cells. siRNA-transfected NTERA2/D1 cells   
were co-cultured with L-WT, L–Dll1, or L–Jagged-1   
cells.  Human  Notch  target  gene  expression 
was assessed by quantitative RT-PCR. Mean ± 
SD of relative values is shown for four indepen-
dent experiments. *, P < 0.05.JCB • VOLUME 187 • NUMBER 3 • 2009   350
for controlling lineage specification (Strizzi et al., 2005; Bolós 
et al., 2007). In addition, these signaling pathways are involved 
in the progression of tumors in various types of cancer (Bianco 
et al., 2005; Bolós et al., 2009). Therefore, our findings have a 
potential impact on delineating the mechanism by which Notch 
and Nodal/CR-1 signaling pathways may regulate embryo-
genesis and carcinogenesis.
Materials and methods
Cell lines
COS-7, CHO, 293T, and NTERA2/D1 cells were purchased from Ameri-
can Type Culture Collection. F9 WT and Cr
/ cells were provided by   
M. Sanicola (Biogen Idec, Cambridge, MA). L-WT, L-Dll1, and L–Jagged-1 
cells were provided by P. Stanley (Albert Einstein College of Medicine, 
Bronx, NY). Transfections were performed using Lipofectamine 2000 (Invit-
rogen) for COS-7, CHO, 293T, and F9 cells or using Nucleofector (Lonza) 
for NTERA2/D1 cells according to the manufacturers’ instructions.
Y2H screening
Automated Y2H screening was performed at Myriad Genetics as previ-
ously described (Garrus et al., 2001). A bait plasmid coding human CR-1 
(aa 34–161) fused to the C terminus of the Gal4 DNA–binding domain 
(aa 1–147) was transformed into yeast strain PNY200 (MAT- ura3-52 
ade2-101 trp1-901 his3-200 leu2-3, 112 gal4gal80). Prey constructs 
were generated from double poly(A)-selected mRNA of mouse embryo or 
of human colon. The prey constructs were transformed into the yeast 
strain BK100 (MATa ura3-52 ade2-101 trp1-901 his3-200 leu2-3, 112 
gal4gal80GAL2-ADE2  LYS2::GAL1-HIS3  met2::GAL7-lacZ).  PNY200 
cells (bait) were mated with BK100 cells (prey). Resulting diploid yeast 
cells were then selected in the presence of 3 mM 3-amino-1, 2, 4-triazole 
for the ability to synthesize tryptophan (bait), leucine (prey), histidine (bait–
prey interaction), and adenine (bait–prey interaction).
Expression plasmids
All CR-1–, CFC1-, and Notch2-derived constructs were based on human 
sequences,  whereas  all  Notch1-,  Notch3-,  and  Notch4-related  vectors 
were based on mouse sequences. WT CR-1, CR-Flag, and CFC-Flag ex-
pression vectors were described previously (Watanabe et al., 2008). CR-1 
deletions (EGF, CFC, and EGFCFC) were generated by PCR-based   
methods. GFP fusion CR-1 constructs were cloned into the pCI-neo expression 
vector (Promega). N1FL-HA, LNR, DlEGF + NEGF, DlEGF + NECD,   
2–6× EGF, N1ICD, and Dll-HA were previously described (Sakamoto et al., 
2002, 2005). N1EGF8–24 was generated by a PCR-based method with 
the Flag-N1-HA expression vector as a template. NMfeI is a self-ligated 
product after MfeI digestion of the Flag-N1-HA vector. N1EGF30-, N1EGF35-, 
and N1LNR-YFP were generated by PCR and cloned into the p3× Flag–
Myc-CMV-24 expression vector (Sigma-Aldrich). WT N1FL was a gift from 
R. Kopan (Washington University in St. Louis, St. Louis, MO). The N1-RQRR 
mutant  construct  was  generated  by  mutagenesis.  N2FL-Myc,  N3FL-HA, 
R1031C mutant Notch3 from a CADASIL patient (N3FLmt-HA), N3ICD-HA, 
N3ECD-Myc, and TP-1 reporter were provided by S. Artavanis-Tsakonas 
(Harvard University, Cambridge, MA). N4FL-V5 was generated by intro-
ducing mouse Notch4 cDNA (gift from Y. Shirayoshi, Tottori University, Tot-
tori, Japan) into the EcoRI–NotI site of the pEF6/V5-His TOPO TA expression 
vector (Invitrogen). This construct is C-terminally truncated at an intrinsic 
NotI site (truncation of aa 1,890–1,964). DsRed-Golgi and a mouse furin 
expression vector were purchased from Takara Bio Inc. and Thermo Fisher 
Scientific, respectively. All primer sequences used for vector construction 
are provided in Table II.
IP, sequential IP, and Western blot analysis
Whole cell lysates were prepared using IP buffer (2 mM Na orthovanadate, 
50 mM NaF, 20 mM Hepes, 150 mM NaCl, 1.5 mM MgCl2, 5 mM Na 
pyrophosphate, 10% glycerol, and 0.2% Triton X-100). IP was performed 
using anti–Flag M2, anti-HA, anti-V5, anti-Myc affinity gel (Sigma-Aldrich), 
or SA agarose (Invitrogen). Sequential IP was performed by eluting the 
Flag-precipitated proteins with 3× Flag peptide followed by a second IP. 
Proteins were separated on 4–20% SDS-PAGE gels (Invitrogen). Epitope 
tags were detected with peroxidase conjugates of anti–Flag M2, anti-Myc 
(Sigma-Aldrich), anti-HA (Roche), and anti-V5 (Invitrogen) antibodies.   
Endogenous human CR-1 and mouse Cr-1 were detected with B3F6 mAb 
To address the biological significance of our findings in 
a physiological setting, we used mouse and human EC cells in 
which both Cr-1/CR-1 and Notch proteins are endogenously ex-
pressed (Figs. 1 E and 5, A–C and G). F9 mouse EC cells ex-
press Cr-1 and several Notch receptors, as detected by RT-PCR 
and Western blot analysis (Fig. 5, A–C). We obtained a Cr-1–null 
variant (Cr
/) of F9 cells, which was generated by gene target-
ing. We confirmed that the endogenous expression of Cr-1 was 
absent in F9 Cr
/ cells (Fig. 5, A and C). Notch1, -2, and -3 re-
ceptors were equally expressed in F9 WT and Cr
/ cells (Fig. 5, 
A and B). F9 WT cells showed little expression of Notch4, which, 
in contrast, was detected in Cr
/ cells (Fig. 5, A and B). Western 
blotting for endogenous Notch1 revealed the expression of the 
300-kD precursor form and the 120-kD mature form of Notch1 in 
F9 WT and Cr
/ cells (Fig. 5 C). However, there was a reduced 
expression of the 300-kD form in F9 WT cells, as compared with 
F9 Cr
/ cells, suggesting an enhancement of Notch1 processing 
by the presence of Cr-1. In fact, the cell surface expression level 
of Notch1 is higher in F9 WT cells compared with Cr
/ cells 
(Fig. 5, D and E). Ligand-induced activation of the TP-1 reporter 
was reduced in F9 Cr
/ cells, as compared with F9 WT cells, and 
the difference was enhanced when ectopic N1FL was expressed 
(Fig. 5 F). Like F9 WT cells, NTERA2/D1 human EC cells, from 
which human CR-1 was originally cloned (Ciccodicola et al.,   
1989) expressed Notch1, -2, and -3 but not Notch4 (Fig. 1 E). We 
used siRNAs to knock down endogenous CR-1 expression in   
NTERA2/D1 cells. We designed two siRNAs, of which siCR-1_1   
showed almost a complete knockdown and siCR-1_2 showed   
an 70% knockdown efficiency of the CR-1 protein (Fig. 5, 
G and H). We performed a co-culture assay of siRNA-transfected   
NTERA2/D1 cells with L-WT, L-Dll1, or L–Jagged-1 cells to as-
sess the effect of siRNA-mediated knockdown of CR-1 on ligand- 
induced Notch target gene expression using quantitative RT-PCR   
with human-specific primer sets that do not cross-react with mouse 
cDNAs from L cells (Fig. S3). As shown in Fig. 5 I, CR-1 knock-
down in NTERA2/D1 cells significantly suppressed to varying   
degrees the induction of the Notch target genes (HES-1 and HEY-1 
and -2) after Notch ligand stimulation.
In this study, we discovered a novel mechanism for sensi-
tization of the Notch signaling pathway by CR-1 through the 
direct binding to the intracellular pro form of the Notch recep-
tors. Finally, the mechanism by which CR-1 facilitates Notch 
receptor signaling is by the enhancement of S1 cleavage through 
a furin-like convertase. In fact, the CR-1–binding domain of 
Notch1 is proximal to the S1 cleavage sites (Fig. 4 C). This pro-
cessing step is essential for the cell surface expression of Notch 
receptors and for ligand-induced activation of the Notch recep-
tors, at least in mammals (Nichols et al., 2007). The enhanced 
proteolytic processing of Notch is initiated by CR-1 in intra-
cellular ER/Golgi vesicles that are being exocytosed. This seems 
likely because binding of CR-1 to Notch could not be detected 
on the cell surface and because blockade of glycosylation or 
Golgi to membrane trafficking was unable to perturb binding. 
We also demonstrated a role of endogenous CR-1/Cr-1 in po-
tentiating the Notch signaling pathway in EC cells.
Both Notch and Nodal/CR-1 signaling pathways are es-
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Table II.  Oligonucleotide DNA/RNAs used in this study
Name Sequence Description Product size
Primers for CR-1 mutants
CR-1–F-NotI 5-GCGGCCGCGCTGGGCCATCAGGAA-3 Forward
CR-1EGF-F 5-CCATGGGGATACAGCACAGTAAAGAGAACTGTGGGTCTGT-3 Deletion
CR-1EGF-R 5-ACAGACCCACAGTTCTCTTTACTGTGCTGTATCCCCATGG-3 Deletion
CR-1CFC-F 5-AGCACGATGTGCGCAAAGAGGGCCTTGTGATGGATGAGCA-3 Deletion
CR-1CFC-R 5-TGCTCATCCATCACAAGGCCCTCTTTGCGCACATCGTGCT-3 Deletion
CR-1EC-F 5-CCCATGGGGATACAGCACAGTGGCCTTGTGATGGATGAGCAC-3 Deletion
CR-1EC-R 5-GTGCTCATCCATCACAAGGCCACTGTGCTGTATCCCCATGGG-3 Deletion
CR-1–R-EcoRI 5-GAATTCTTAATAGTAGCTTTGTATAGA-3 Reverse
Primers for Notch1 mutants
N1MfeI-F 5-CAATTGCCGCTGCCCACCGGA-3 Forward
N1EGF8–24-F 5-GGACGGGTCAGTACTGTACAGAGGACATCAATGAATGTG-3 Deletion
N1EGF8–24-R 5-GCACATTCATTGATGTCCTCTGTACAGTACTGACCCGTC-3 Deletion
N1MfeI-R 5-CAATTGGCACCATTTTGGCAG-3 Reverse
N1EGF30-F-EcoRI 5-GAATTCAGAGGTGGACGAGTGCTCACCT-3 Forward
N1EGF35-F-EcoRI 5-GAATTCAGATGCCCGCACTTGTGGCAGC-3 Forward
N1LNR-F-EcoRI 5-GAATTCAGAGCTGCCTGAGTGCCAGGTG-3 Chimeric
N1-YFP-F 5-CGCAAGCGCCGGCGGCAGCATGTGAGCAAGGGCGAGGAGCTG-3 Chimeric
N1-YFP-R 5-CAGCTCCTCGCCCTTGCTCACATGCTGCCGCCGGCGCTTGCG-3 Chimeric
YFP-R-XbaI 5-TCTAGACTTGTACAGCTCGTCCATGCC-3 Reverse
N1-RQRR-F 5-GTACCAGTGGTGGGGAGCTGGACCCCAT-3 Mutagenesis
N1-RQRR-R 5-ATGGGGTCCAGCTCCCCACCACTGGTAC-3 Mutagenesis
PCR primers
a
mNotch1-F 5-ACAACAACGAGTGTGAGTCC-3 221 bp
mNotch1-R 5-ACACGTGGCTCCTGTATATG-3 221 bp
mNotch2-F 5-TGACTGTTCCCTCACTATGG-3 150 bp
mNotch2-R 5-CACGTCTTGCTATTCCTCTG-3 150 bp
mNotch3-F 5-AGATCAATGAGTGTGCATCC-3 158 bp
mNotch3-R 5-GCAGACTCCATGACTACAGG-3 158 bp
mNotch4-F 5-CTCTTGCCACTCAATTTCCCT-3 188 bp
mNotch4-R 5-TTGCAGAGTTGGGTATCCCTG-3 188 bp
hNotch1-F 5-AGGACCTCATCAACTCACACGC-3 130 bp
hNotch1-R 5-TCTTTGTTAGCCCCGTTCTTCAG-3 130 bp
hNotch2-F 5-CCGTGTTGACTTCTGCTCTCTCAC-3 170 bp
hNotch2-R 5-CCTACTACCCTTGGCATCCTTTG-3 170 bp
hNotch3-F 5-TCTCAGACTGGTCCGAATCCAC-3 171 bp
hNotch3-R 5-ACACTTGCCTCTTGGGGGTAAC-3 171 bp
hNotch4-F 5-ATGCGAGGAAGATACGGAGTGG-3 112 bp
hNotch4-R 5-TCGGAATGTTGGAGGCAGAAC-3 112 bp
hHes-1–F
b 5-AGGCGGACATTCTGGAAATG-3 103 bp
hHes-1–R
b 5-CGGTACTTCCCCAGCACACTT-3 103 bp
hHey-1–F
b 5-GAAACTTGAGTTCGGCTCTAGG-3 113 bp
hHey-1–R
b 5-GCTTAGCAGATCCTTGCTCCAT-3 113 bp
hHey-2–F
b 5-GGCGTCGGGATCGGATAAATA-3 127 bp
hHey-2–R
b 5-AAGTAGCCTTTACCCCCTGTT-3 127 bp
hGAPDH-F
b 5-GGACCTGACCTGCCGTCTAGAA-3 141 bp
hGAPDH-R
b 5-GGTGTCGCTGTTGAAGTCAGAG-3 141 bp
mCr-1–F 5-ATGGACGCAACTGTGAACATGATGTTCGCA-3 174 bp
mCr-1–R 5-CTTTGAGGTCCTGGTCCATCACGTGACCAT-3 174 bp
mHes-1–F
c 5-TCCTAACGCAGTGTCACCTTCCAG-3 148 bp
mHes-1–R
c 5-CCAAGTTCGTTTTTAGTGTCCGTC-3 148 bp
mHey-1–F
c 5-CAGGAGGGAAAGGTTATTTTGACG-3 163 bp
mHey-1–R
c 5-TAGTTGTTGAGATGGGAGACCAGGCG-3 163 bp
mGAPDH-F
c 5-AATGTGTCCGTCGTGGATCT-3 256 bp
mGAPDH-R
c 5-CCCTGTTGCTGTAGCCGTAT-3 256 bp
siRNAs
siCR-1_1-S 5-CGCUUCUCUUACAGUGUGA-3
siCR-1_1-AS 5-UCACACUGUAAGAGAAGCG-3
siCR-1_2-S 5-GAAUUAUAUGUUCAGAUUA-3
siCR-1_2-AS 5-UAAUCUGAACAUAUAAUUC-3
Blank cells indicate that the information is not applicable.
aUsed for both quantitative PCR and conventional RT-PCR; 
bHuman specific (no cross-reactivity with mouse cDNA); 
cMouse specific (no cross-reactivity with human cDNA).JCB • VOLUME 187 • NUMBER 3 • 2009   352
siRNA treatment
Sequences for siCR-1_1 and siCR-1_2 are provided in Table II. Control 
siRNA targeting firefly luciferase mRNA was purchased from Thermo Fisher 
Scientific. Lonza nucleofections were performed with 2 × 10
6 subconfluent 
NTERA2/D1 cells in the L kit (Lonza) containing 1 µM of each siRNA or 
0.5 µg of GFP control vector and plated into 6-well plates. After 16 h of 
nucleofection, 5 × 10
6 L cells were seeded onto a sheet of NTERA2/D1 
cells and incubated for 30 h. RNA extraction and quantitative RT-PCR were 
performed as described in the previous section.
Statistical analysis
Two-tailed Student’s t test was used to determine the statistical significance 
of the quantitative results. Results with a p-value <0.05 were considered 
statistically significant.
Online supplemental material
Fig. S1 shows a co-IP assay of Cr-1 and Notch1 in F9 cells and a deletion 
analysis of Notch3 proteins for binding to CR-1. Fig. S2 shows colocaliza-
tion of CR-1 and Notch1 proteins with a Golgi marker and the effect of 
soluble CR-1 on Notch signaling activity. Fig. S3 shows the amplification 
plots of quantitative RT-PCR confirming the specificity of human- or mouse-
specific primers used in this study. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200905105/DC1.
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(Biogen Idec) and with anti–mouse Cr-1 rabbit polyclonal antibody (Cell 
Signaling Technology), respectively. Human Notch1 and -2 and mouse 
Notch1 proteins were detected with rat Notch1 mAb (bTan 20; Devel-
opmental  Studies  Hybridoma  Bank),  rat  Notch2  mAb  (C651.6DbHN;   
Developmental Studies Hybridoma Bank), and mouse Notch1 mAb (mN1A; 
Santa Cruz Biotechnology, Inc.), respectively. Endogenous CR-1 and human 
and mouse Notch1 proteins were immunoprecipitated with anti–CR-1 goat 
polyclonal antibody (V17; Santa Cruz Biotechnology, Inc.), anti–human 
Notch1 polyclonal antibodies (C20 [Santa Cruz Biotechnology, Inc.] and 
AF5317 [R&D Systems]), and mouse Notch1 mAb (mN1A). Densitometric 
quantification of band intensity was performed using Labworks software 
(UVP, Inc.).
Cell surface biotinylation
24 h after transfection, 2 × 10
7 cells were washed with PBS, pH 8.0, four 
times  and  incubated  with  2  mM  N-hydroxysuccinimide–PEG4-biotin 
(Thermo Fisher Scientific) for 30 min on ice. The reaction was quenched by 
washing with PBS containing 100 mM glycine.
Immunofluorescence
Transiently transfected COS-7 cells were fixed in 4% PFA and permeabil-
ized with 0.2% Triton X-100. After blocking with PBS containing 10% 
BSA and 10% normal goat serum, samples were incubated with anti-HA 
antibody (Covance) for 1 h at RT. Primary antibody was then labeled with 
Alexa  Fluor  596–conjugated  secondary  antibody  (Invitrogen).  Counter-
staining for nuclei was performed with DAPI, and samples were mounted 
with  ProLong  Gold  antifade  reagent  (Invitrogen).  Images  were  taken  at   
RT with a confocal system (LSM 710 NLO; Carl Zeiss, Inc.) with an inverted 
microscope (Axiovert 200M; Carl Zeiss, Inc.) equipped with a 63× NA 1.4 
Plan-Apochromat oil immersion objective lens. Images were collected with 
AIM software (Carl Zeiss, Inc.) using a multitrack configuration.
FACS analysis
As described previously (Watanabe et al., 2007b), cells were collected 
with enzyme-free cell dissociation buffer (PBS containing 4 mM EDTA). 
After washing with ice-cold FACS buffer (PBS with 0.1% BSA), 1.0 × 10
5 
cells were incubated for 20 min with anti–human CR-1 phycoerythrin (PE)-
conjugated antibody (FAB2772P; R&D Systems) at a dilution of 1:50 or 
PE-conjugated  anti-Notch1  mAb  (BioLegend).  Cells  were  then  pelleted, 
resuspended in 500 µl of ice-cold FACS buffer, and analyzed using a 
FACScan instrument (BD).
Sucrose gradient isolation of lipid rafts
As described previously (Watanabe et al., 2007a), cells were washed with 
cold PBS, scraped into 2 ml MBS (2-[N-morpholino] ethanesulfonic acid–
buffered saline, 25 mM 2-[N-morpholino] ethanesulfonic acid, pH 6.5, 
and 0.15 M NaCl) containing 1% Triton X-100, and solubilized for 20 min 
at 4°C. After homogenization by 10 strokes with a tight-fitting homoge-
nizer (Dounce; Wheaton Science Products), samples were adjusted to 40% 
sucrose by the addition of 2 ml of 80% sucrose. Then, a 5–40% discontinu-
ous sucrose gradient was formed and centrifuged at 40,000 rpm for 20 h 
in an SW40Ti rotor (Beckman Coulter). 12 1-ml fractions were removed 
from the top of the tubes and analyzed by Western and dot blotting.
Dual luciferase assay
Dual  luciferase  assay  using  a  co-culture  system  with  ligand-expressing 
L cells was performed as previously described with slight modifications 
(Stahl et al., 2008). CHO or F9 cells were plated in 24-well culture plates 
(5 × 10
5 cells/well) and were transiently transfected with TP-1 reporter,   
TK-renilla, and an N1FL and/or a CR-Flag expression vector. 16 h after 
transfection, L cells were plated onto the CHO or F9 cells (5 × 10
6 cells/
well) and incubated for 30 h. Dual luciferase assays (Promega) were per-
formed according to manufacturer’s instructions.
RNA extraction and RT-PCR
Total RNA was extracted using the RNA mini kit (QIAGEN). On-column 
DNase treatment was performed for all RNA extractions. cDNA was pre-
pared from 1 µg of total RNA using the Retroscript kit (Applied Biosystems). 
All nonquantitative PCR described in this study was performed at 25 cycles 
of 94°C (30 s), 55°C (30 s), and 72°C (30 s) using the PCR master mix 
(QIAGEN). Quantitative PCR was performed using an MX3000P PCR and 
Brilliant SYBR green QPCR master mix (Agilent Technologies). Comparative 
analyses were performed between the genes of interest and the house-
keeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH). All 
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